KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Zimmer Biomet Holdings (ZBH) Shares Outstanding (Weighted Average) (2022 - 2026)

Zimmer Biomet Holdings has reported Shares Outstanding (Weighted Average) over the past 11 years, most recently at $195.0 million for Q1 2026.

  • For Q1 2026, Shares Outstanding (Weighted Average) fell 1.96% year-over-year to $195.0 million; the TTM value through Mar 2026 reached $195.0 million, down 1.96%, while the annual FY2025 figure was $198.0 million, 2.51% down from the prior year.
  • Shares Outstanding (Weighted Average) for Q1 2026 was $195.0 million at Zimmer Biomet Holdings, down from $198.0 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $209.8 million in Q3 2022 and troughed at $195.0 million in Q1 2026.
  • A 5-year average of $204.0 million and a median of $205.2 million in 2024 define the central range for Shares Outstanding (Weighted Average).
  • Biggest five-year swings in Shares Outstanding (Weighted Average): dropped 0.38% in 2023 and later decreased 3.41% in 2025.
  • Year by year, Shares Outstanding (Weighted Average) stood at $209.6 million in 2022, then dropped by 0.43% to $208.7 million in 2023, then decreased by 2.68% to $203.1 million in 2024, then dropped by 2.51% to $198.0 million in 2025, then dropped by 1.52% to $195.0 million in 2026.
  • Business Quant data shows Shares Outstanding (Weighted Average) for ZBH at $195.0 million in Q1 2026, $198.0 million in Q4 2025, and $198.3 million in Q3 2025.